These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27185426)

  • 1. Topical minocycline foam for moderate to severe acne vulgaris: Phase 2 randomized double-blind, vehicle-controlled study results.
    Shemer A; Shiri J; Mashiah J; Farhi R; Gupta AK
    J Am Acad Dermatol; 2016 Jun; 74(6):1251-2. PubMed ID: 27185426
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of a novel topical minocycline foam for the treatment of moderate to severe acne vulgaris: A phase 3 study.
    Raoof TJ; Hooper D; Moore A; Zaiac M; Sullivan T; Kircik L; Lain E; Jankicevic J; Stuart I
    J Am Acad Dermatol; 2020 Apr; 82(4):832-837. PubMed ID: 31163231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel topical minocycline foam for the treatment of moderate-to-severe acne vulgaris: Results of 2 randomized, double-blind, phase 3 studies.
    Gold LS; Dhawan S; Weiss J; Draelos ZD; Ellman H; Stuart IA
    J Am Acad Dermatol; 2019 Jan; 80(1):168-177. PubMed ID: 30165171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic Comparison of Once-Daily Topical Minocycline Foam 4% vs Oral Minocycline for Moderate-to-Severe Acne.
    Jones TM; Ellman H; deVries T
    J Drugs Dermatol; 2017 Oct; 16(10):1022-1028. PubMed ID: 29036256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical Minocycline Foam 4%: A Review in Acne Vulgaris.
    Paik J
    Am J Clin Dermatol; 2020 Jun; 21(3):449-456. PubMed ID: 32468355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial.
    Ozolins M; Eady EA; Avery AJ; Cunliffe WJ; Po AL; O'Neill C; Simpson NB; Walters CE; Carnegie E; Lewis JB; Dada J; Haynes M; Williams K; Williams HC
    Lancet; 2004 Dec 18-31; 364(9452):2188-95. PubMed ID: 15610805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris.
    Zaenglein AL; Shamban A; Webster G; Del Rosso J; Dover JS; Swinyer L; Stein L; Lin X; Draelos Z; Gold M; Thiboutot D
    J Drugs Dermatol; 2013 Jun; 12(6):619-25. PubMed ID: 23839176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amzeeq (minocycline foam 4%) for topical treatment of acne vulgaris.
    Gupta AK; Bruce A; Vincent KD; Abramovits W
    Skinmed; 2020; 18(6):354-357. PubMed ID: 33397564
    [No Abstract]   [Full Text] [Related]  

  • 9. Topical minocycline foam 4%: Results of four phase 1 studies evaluating the potential for phototoxicity, photoallergy, sensitization, and cumulative irritation.
    Dosik J; Ellman H; Stuart I
    J Immunotoxicol; 2019 Dec; 16(1):133-139. PubMed ID: 31179779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minocycline Topical Foam: A New Drug for the Treatment of Acne.
    Onge ES; Mobley WC
    Ann Pharmacother; 2021 Jan; 55(1):105-110. PubMed ID: 32618475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallel-group study.
    Leyden J; Thiboutot DM; Shalita AR; Webster G; Washenik K; Strober BE; Shupack J
    Arch Dermatol; 2006 May; 142(5):605-12. PubMed ID: 16702498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minocycline foam (Amzeeq) for acne.
    Med Lett Drugs Ther; 2020 May; 62(1597):68-70. PubMed ID: 32555112
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety and efficacy comparison of minocycline microgranules vs lymecycline in the treatment of mild to moderate acne: randomized, evaluator-blinded, parallel, and prospective clinical trial for 8 weeks.
    Ocampo-Candiani J; Velazquez-Arenas LL; de la Fuente-Garcia A; Trevino-Gomezharper C; Berber A
    J Drugs Dermatol; 2014 Jun; 13(6):671-6. PubMed ID: 24918556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of a new extended-release formulation of minocycline.
    Fleischer AB; Dinehart S; Stough D; Plott RT; ;
    Cutis; 2006 Oct; 78(4 Suppl):21-31. PubMed ID: 17436826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind comparison of topical clindamycin and oral minocycline in the treatment of acne vulgaris.
    Sheehan-Dare RA; Papworth-Smith J; Cunliffe WJ
    Acta Derm Venereol; 1990; 70(6):534-7. PubMed ID: 1981436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the efficacy and safety of lymecycline and minocycline in patients with moderately severe acne vulgaris.
    Grosshans E; Belaïch S; Meynadier J; Alirezai M; Thomas L
    Eur J Dermatol; 1998; 8(3):161-6. PubMed ID: 9649660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy with methyl aminolaevulinate 80 mg g(-1) for severe facial acne vulgaris: a randomized vehicle-controlled study.
    Pariser DM; Eichenfield LF; Bukhalo M; Waterman G; Jarratt M;
    Br J Dermatol; 2016 Apr; 174(4):770-7. PubMed ID: 26663215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once-Daily Oral Sarecycline 1.5 mg/kg/day Is Effective for Moderate to Severe Acne Vulgaris: Results from Two Identically Designed, Phase 3, Randomized, Double-Blind Clinical Trials.
    Moore A; Green LJ; Bruce S; Sadick N; Tschen E; Werschler P; Cook-Bolden FE; Dhawan SS; Forsha D; Gold MH; Guenthner S; Kempers SE; Kircik LH; Parish JL; Rendon MI; Rich P; Stein-Gold L; Tyring SK; Weiss RA; Nasir A; Schmitz C; Boodhoo TI; Kaoukhov A; Berk DR
    J Drugs Dermatol; 2018 Sep; 17(9):987-996. PubMed ID: 30235387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-ranging efficacy of new once-daily extended-release minocycline for acne vulgaris.
    Stewart DM; Torok HM; Weiss JS; Plott RT;
    Cutis; 2006 Oct; 78(4 Suppl):11-20. PubMed ID: 17436825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating FMX-101 as a promising therapeutic for the treatment of acne.
    Valente Duarte de Sousa IC
    Expert Opin Pharmacother; 2020 May; 21(7):741-746. PubMed ID: 32037906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.